Clinical Study of 18F -FAPI-RGD in Renal Tumor
NCT05976607 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35
Last updated 2025-04-17
Summary
The goal of this observational study is to learn about the value of 18F-FAPI-RGD PET/CT imaging in Renal Tumor. Participants will undergo clinical evaluation and 18F-FAPI-RGD PET/CT examination.
Conditions
- Renal Tumor
Sponsors & Collaborators
-
Sichuan Provincial People's Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-20
- Primary Completion
- 2024-01-15
- Completion
- 2024-02-20
Countries
- China
Study Locations
More Related Trials
-
Application of Al18F-NOTA-FAPI PET/CT in Malignant Tumors Expressing Fibroblast-activated Proteins
NCT05749302 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
18F-AlF-FAPi-04 PET/CT Imaging in Patients With Solid Tumor
NCT06126705 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
FAP-targeting PET/CT for Noninvasive Monitoring of Renal Fibrosis
NCT06563765 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
18F-FAPI-04 PET/CT and PET/MR in Patients With Various Types of Malignant Tumors
NCT06557590 ·Status: RECRUITING
-
MRI Functional Imaging Characteristics and Fat Quantification of CT-fat-free Renal Neoplasms: Relationships With Histological Classifications and Molecular Markers
NCT06126159 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
18F-FAPI and 18F-FDG PET/CT in Patients With Various Types of Cancer
NCT05485792 ·Status: UNKNOWN ·Phase: NA
-
18F-FAPI PET/CT in Patients With Various Types of Cancer
NCT05810324 ·Status: UNKNOWN ·Phase: NA
-
CD70-targeted immunoPET Imaging of Kidney Cancer
NCT06680089 ·Status: RECRUITING ·Phase: PHASE2
-
Study of 18F-FAPI Applied to Gastrointestinal Cancer
NCT05788874 ·Status: UNKNOWN
-
Tracer Targeting FAP PET Imaging in Patients
NCT05691894 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
68Ga-FAP-RGD PET/CT : Dosimetry and Preliminary Clinical Translational Studies
NCT05515783 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
68Ga-FAPI-RGD PET/CT for Dual Integrin αvβ3 and FAP-targeted Imaging in Patients With Various Types of Cancer and Compared With 18F-FDG
NCT05543317 ·Status: COMPLETED ·Phase: NA
-
[18F]Fluciclatide PET Imaging of Pazopanib Response
NCT01961583 ·Status: TERMINATED ·Phase: PHASE2
-
FAP PET/CT or PET/MR Production in the Diagnosis, Staging, and Efficacy Assessment of Malignant Tumors Application
NCT06270394 ·Status: COMPLETED ·Phase: NA
-
68Ga-DOTA-F2 PET/CT in Patients With Various Types of Cancer
NCT05637034 ·Status: UNKNOWN ·Phase: NA
-
Study of 18F-Thretide PET/CT in Patients With Prostate Cancer
NCT05516329 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
NCT06937112 ·Status: RECRUITING
-
18F-mFBG PET Imaging in the Evaluation of Neuroblastoma
NCT06852807 ·Status: RECRUITING
-
68Ga-PSMA PET in the Renal Cell Carcinoma
NCT04987086 ·Status: RECRUITING ·Phase: NA
-
A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors
NCT06148220 ·Status: RECRUITING ·Phase: NA
-
Evaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms
NCT06791226 ·Status: RECRUITING ·Phase: NA
-
Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer
NCT05392205 ·Status: COMPLETED ·Phase: NA
-
Measuring Treatment Response in Metastatic Renal Cell Cancer Using FPIA PET/CT
NCT04802824 ·Status: COMPLETED
-
Characterizing Breast Cancer With Al18F-NOTA-FAPI-04 PET/CT (PFB-02)
NCT05574920 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Application of Al18F-octreotide PET/CT in Tumors With Positive SSTR Expression
NCT05749289 ·Status: RECRUITING ·Phase: PHASE2/PHASE3